Linked Data API

Show Search Form

Search Results

1140170
star this property registered interest false more like this
star this property date less than 2019-07-18more like thismore than 2019-07-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Heart Diseases and Strokes: Females more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will respond to the recommendations in the report entitled Call for Action: Inquiry into heart attack and stroke, published by the all-party Parliamentary group on women’s health in July 2019; and if he will make a statement. more like this
star this property tabling member constituency Dewsbury more like this
star this property tabling member printed
Paula Sherriff more like this
star this property uin 279083 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-07-23more like thismore than 2019-07-23
star this property answer text <p>NHS England has acknowledged the recently published report and will be considering the content.</p><p>Improving the prevention and treatment of heart attacks and stroke are key aims in the NHS Long Term Plan, with an important milestone being for the National Health Service to help prevent up to 150,000 heart attacks, strokes and dementia cases over the next 10 years. The NHS Long Term Plan highlights that outcomes from heart attack and stroke can be improved, and that there should be a focus on inequalities.</p><p><strong> </strong></p><p><strong> </strong></p> more like this
unstar this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
less than 2019-07-23T16:54:04.3Zmore like thismore than 2019-07-23T16:54:04.3Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
4426
unstar this property label Biography information for Paula Sherriff more like this
1140171
star this property registered interest false more like this
star this property date less than 2019-07-18more like thismore than 2019-07-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Heart Diseases and Strokes: Females more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve (a) outcomes, (b) early identification and (c) treatment of heart attack and stroke for women. more like this
star this property tabling member constituency Dewsbury more like this
star this property tabling member printed
Paula Sherriff more like this
star this property uin 279084 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-07-23more like thismore than 2019-07-23
star this property answer text <p>Improving the prevention and treatment of heart attacks and stroke are key aims in the NHS Long Term Plan, with an important milestone being for the National Health Service to help prevent up to 150,000 heart attacks, strokes and dementia cases over the next 10 years. The NHS Long Term Plan highlights that outcomes from heart attack and stroke can be improved, and that there should be a focus on inequalities.</p><p>In addition, addressing variations in outcomes from cardiovascular disease (CVD), such as heart attacks and stroke, is one of Public Health England’s (PHE) top priorities, and in February 2019, PHE announced new 10-year CVD ambitions for England, which are intended to complement the NHS Long Term Plan and are the first ever national ambitions to improve the detection and treatment of the major causes of CVD.</p> more like this
unstar this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
less than 2019-07-23T16:48:22.11Zmore like thismore than 2019-07-23T16:48:22.11Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
4426
unstar this property label Biography information for Paula Sherriff more like this
1140209
star this property registered interest false more like this
star this property date less than 2019-07-18more like thismore than 2019-07-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cystic Fibrosis: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent discussions there have been between Vertex Pharmaceuticals and NHS England with on cystic fibrosis medicines. more like this
star this property tabling member constituency Bristol East more like this
star this property tabling member printed
Kerry McCarthy more like this
star this property uin 278928 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-07-23more like thismore than 2019-07-23
star this property answer text <p>Discussions with Vertex, including meetings, are ongoing.</p><p>NHS England and NHS Improvement are leading the negotiations with Vertex and have made a revised and improved offer to Vertex that would provide immediate funding for Orkambi and Symkevi in advance of a positive assessment by the National Institute for Health and Care Excellence (NICE), in addition to expanded access to Kalydeco which is already funded by the National Health Service for certain patients.</p><p>The Government fully supports NICE, NHS England and NHS Improvement in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the NHS, and it is not for Ministers to intervene in this process. The Department’s approach remains to strongly urge Vertex to accept NHS England’s and NHS Improvement’s generous offer, but in the absence of a deal, we have asked NHS England and NHS Improvement to continue to explore all options to ensure patients can access treatments as soon as possible.</p>
unstar this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property grouped question UIN 278929 more like this
star this property question first answered
less than 2019-07-23T16:49:59.47Zmore like thismore than 2019-07-23T16:49:59.47Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
1491
unstar this property label Biography information for Kerry McCarthy more like this
1140210
star this property registered interest false more like this
star this property date less than 2019-07-18more like thismore than 2019-07-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cystic Fibrosis: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will set a deadline for NHS England and Vertex Pharmaceuticals to come to an agreement to enable access to cystic fibrosis medicines produced by that company. more like this
star this property tabling member constituency Bristol East more like this
star this property tabling member printed
Kerry McCarthy more like this
star this property uin 278929 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-07-23more like thismore than 2019-07-23
star this property answer text <p>Discussions with Vertex, including meetings, are ongoing.</p><p>NHS England and NHS Improvement are leading the negotiations with Vertex and have made a revised and improved offer to Vertex that would provide immediate funding for Orkambi and Symkevi in advance of a positive assessment by the National Institute for Health and Care Excellence (NICE), in addition to expanded access to Kalydeco which is already funded by the National Health Service for certain patients.</p><p>The Government fully supports NICE, NHS England and NHS Improvement in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the NHS, and it is not for Ministers to intervene in this process. The Department’s approach remains to strongly urge Vertex to accept NHS England’s and NHS Improvement’s generous offer, but in the absence of a deal, we have asked NHS England and NHS Improvement to continue to explore all options to ensure patients can access treatments as soon as possible.</p>
unstar this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property grouped question UIN 278928 more like this
star this property question first answered
less than 2019-07-23T16:49:59.517Zmore like thismore than 2019-07-23T16:49:59.517Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
1491
unstar this property label Biography information for Kerry McCarthy more like this
1140227
star this property registered interest false more like this
star this property date less than 2019-07-18more like thismore than 2019-07-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading 5G: Health Hazards more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what research his Department has conducted on the potential effect on public health of upgrading infrastructure to support 5G. more like this
star this property tabling member constituency Streatham more like this
star this property tabling member printed
Chuka Umunna more like this
star this property uin 279011 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-07-23more like thismore than 2019-07-23
star this property answer text <p>Public Health England (PHE) advises that the guidelines of the International Commission on Non-Ionizing Radiation Protection (ICNIRP) should be adopted and there is no convincing evidence that radio wave exposures below the ICNIRP guideline levels cause adverse health effects. The ICNIRP guidelines cover exposures arising from new 5G base stations, as well as from older technologies.</p><p>Many exposure measurements have been made at publicly accessible locations near to mobile phone base stations, and these have consistently been well within guidelines. It is possible that there may be a small increase in overall exposure to radio waves when 5G is added to an existing network or in a new area; however, the overall exposure is expected to remain low relative to guidelines and as such there should be no consequences for public health.</p><p> </p><p>PHE has published information about exposure to the radio waves from mobile phone base stations, including those for 5G networks, at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health" target="_blank">https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health</a></p><p> </p><p>PHE continues to monitor the health-related evidence applicable to radio waves and is committed to updating its advice as required.</p><p><strong> </strong></p>
unstar this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
less than 2019-07-23T16:52:28.177Zmore like thismore than 2019-07-23T16:52:28.177Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
4128
unstar this property label Biography information for Chuka Umunna more like this
1140302
star this property registered interest false more like this
star this property date less than 2019-07-18more like thismore than 2019-07-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Rehabilitation Centres: County Durham more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the number of residential drug recovery services for women in County Durham. more like this
star this property tabling member constituency Easington more like this
star this property tabling member printed
Grahame Morris more like this
star this property uin 278956 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-07-23more like thismore than 2019-07-23
star this property answer text <p>The Government provides funding to local authorities for their public health responsibilities through a public health grant. It is for individual local authorities to decide their spending priorities based on an assessment of local need, including the need for residential drug treatment services taking account of their statutory duties.</p><p>Future funding for local authority public health functions will be a matter for the Spending Review.</p> more like this
unstar this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property grouped question UIN 278960 more like this
star this property question first answered
less than 2019-07-23T16:50:57.097Zmore like thismore than 2019-07-23T16:50:57.097Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
3973
unstar this property label Biography information for Grahame Morris more like this
1140335
star this property registered interest false more like this
star this property date less than 2019-07-18more like thismore than 2019-07-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Rehabilitation Centres: Finance more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will increase the (a) funding for and (b) provision of residential drug treatment services. more like this
star this property tabling member constituency Easington more like this
star this property tabling member printed
Grahame Morris more like this
star this property uin 278960 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-07-23more like thismore than 2019-07-23
star this property answer text <p>The Government provides funding to local authorities for their public health responsibilities through a public health grant. It is for individual local authorities to decide their spending priorities based on an assessment of local need, including the need for residential drug treatment services taking account of their statutory duties.</p><p>Future funding for local authority public health functions will be a matter for the Spending Review.</p> more like this
unstar this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property grouped question UIN 278956 more like this
star this property question first answered
less than 2019-07-23T16:50:57.143Zmore like thismore than 2019-07-23T16:50:57.143Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
3973
unstar this property label Biography information for Grahame Morris more like this
1140407
star this property registered interest false more like this
star this property date less than 2019-07-18more like thismore than 2019-07-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to tackle the overcharging of medicines to the NHS. more like this
star this property tabling member constituency Newton Abbot more like this
star this property tabling member printed
Anne Marie Morris more like this
star this property uin 279026 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-07-23more like thismore than 2019-07-23
star this property answer text <p>The costs of branded medicines are controlled by the statutory and voluntary schemes for branded medicines. Under those schemes, any price increase needs to be agreed by the Department. For generic medicines, the Department encourages competition between suppliers to drive prices down. This generally works well but there are instances where there is no or not enough competition and prices appear unreasonably high. Section 262 of the National Health Service Act 2006 enables the Secretary of State to limit the price of any medicine not covered by the voluntary scheme for branded medicines. The Department is preparing a public consultation on the use of this power for generic medicines. The Health Service Products (Provision and Disclosure of Information) Regulations 2018 support the powers in the National Health Service Act 2006 by enabling the Secretary of State to require suppliers to provide information about their products including information about the cost of manufacturing those products.</p>
unstar this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property grouped question UIN 279028 more like this
star this property question first answered
less than 2019-07-23T16:46:17.337Zmore like thismore than 2019-07-23T16:46:17.337Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
4249
unstar this property label Biography information for Anne Marie Morris more like this
1140408
star this property registered interest false more like this
star this property date less than 2019-07-18more like thismore than 2019-07-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Synacthen: Prices more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether his Department is aware that synacthen has recently increased in cost from £2.70 per vial to £38 per vial; and if he will make a statement. more like this
star this property tabling member constituency Newton Abbot more like this
star this property tabling member printed
Anne Marie Morris more like this
star this property uin 279027 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-07-23more like thismore than 2019-07-23
star this property answer text <p>The Department agreed the list price increase for Synacthen in March 2015.</p><p>The previous Pharmaceutical Price Regulation Scheme, the current 2019 Voluntary Scheme for Branded Medicines Pricing and Access and our statutory branded medicines pricing scheme all have detailed arrangements for how companies can request an increase to the National Health Service list price for a product.</p><p>Companies must comply with the rules of the relevant scheme when making a price increase request and all price increase requests must receive Departmental approval before they can take effect.</p><p> </p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> more like this
unstar this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
less than 2019-07-23T16:53:15.603Zmore like thismore than 2019-07-23T16:53:15.603Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
4249
unstar this property label Biography information for Anne Marie Morris more like this
1140411
star this property registered interest false more like this
star this property date less than 2019-07-18more like thismore than 2019-07-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether his Department will use the Health Service Products (Provision and Disclosure of Information) Regulations 2018 to prevent price inflation of medicines. more like this
star this property tabling member constituency Newton Abbot more like this
star this property tabling member printed
Anne Marie Morris more like this
star this property uin 279028 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-07-23more like thismore than 2019-07-23
star this property answer text <p>The costs of branded medicines are controlled by the statutory and voluntary schemes for branded medicines. Under those schemes, any price increase needs to be agreed by the Department. For generic medicines, the Department encourages competition between suppliers to drive prices down. This generally works well but there are instances where there is no or not enough competition and prices appear unreasonably high. Section 262 of the National Health Service Act 2006 enables the Secretary of State to limit the price of any medicine not covered by the voluntary scheme for branded medicines. The Department is preparing a public consultation on the use of this power for generic medicines. The Health Service Products (Provision and Disclosure of Information) Regulations 2018 support the powers in the National Health Service Act 2006 by enabling the Secretary of State to require suppliers to provide information about their products including information about the cost of manufacturing those products.</p>
unstar this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property grouped question UIN 279026 more like this
star this property question first answered
less than 2019-07-23T16:46:17.387Zmore like thismore than 2019-07-23T16:46:17.387Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
4249
unstar this property label Biography information for Anne Marie Morris more like this